News
The latest about SetPoint Medical
Press coverage
New Implant Offers Hope for Easing Rheumatoid Arthritis
A surprising new treatment for rheumatoid arthritis
Vagus Nerve Stimulation Proves Effective in Refractory Rheumatoid Arthritis
Electricity Is the New Medical Miracle
Why It’s Time to Take Electrified Medicine Seriously
Stimulating the vagus nerve may reduce symptoms of multiple sclerosis
Press releases
SetPoint Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 15, 2025
SetPoint Medical to Present at Piper Sandler 37th Annual Healthcare Conference
November 25, 2025
SetPoint Medical Announces CMS Transitional Pass-Through Payment Approval for the SetPoint System, the Breakthrough Neuroimmune Modulation Platform
November 24, 2025
Scientific publications
Neuroimmune Modulation for Drug-Refractory Rheumatoid Arthritis: Long-Term Safety and Efficacy in Patients Enrolled in a Pilot Vagus Nerve Stimulation Study
Electrical stimulation of the vagus nerve ameliorates inflammation and disease activity in a rat EAE model of multiple sclerosis
Clinical safety and feasibility of a novel implantable neuroimmune modulation device for the treatment of rheumatoid arthritis: initial results from the randomized, double-blind, sham-controlled RESET-RA study